Q3060837 (Q3060837): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: trying to import one item from austria)
(‎Created claim: summary (P836): In this EFREtop-funded project, we develop complex next-generation biochips and bring together micro and macro in the highest quality. The technologies developed are verified in a clinically relevant environment., translated_summary)
Property / summary
 
In this EFREtop-funded project, we develop complex next-generation biochips and bring together micro and macro in the highest quality. The technologies developed are verified in a clinically relevant environment. (English)
Property / summary: In this EFREtop-funded project, we develop complex next-generation biochips and bring together micro and macro in the highest quality. The technologies developed are verified in a clinically relevant environment. (English) / rank
 
Normal rank
Property / summary: In this EFREtop-funded project, we develop complex next-generation biochips and bring together micro and macro in the highest quality. The technologies developed are verified in a clinically relevant environment. (English) / qualifier
 
point in time: 20 July 2021
Timestamp+2021-07-20T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 07:45, 20 July 2021

Project in Austria 550
Language Label Description Also known as
English
No label defined
Project in Austria 550

    Statements

    0 references
    1,885,933.0 Euro
    0 references
    1 June 2018
    0 references
    31 May 2019
    0 references
    STRATEC Consumables GmbH
    0 references
    50301
    0 references
    In diesem EFREtop-geförderten Projekt entwickeln wir komplexe Biochips der nächsten Generation und bringen Mikro und Makro in höchster Qualität zusammen. Die entwickelten Technologien werden in einem klinisch relevanten Umfeld verifiziert. (German)
    0 references
    In this EFREtop-funded project, we develop complex next-generation biochips and bring together micro and macro in the highest quality. The technologies developed are verified in a clinically relevant environment. (English)
    20 July 2021
    0 references

    Identifiers

    AUST-550
    0 references